Persistent Asthma
17
0
1
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.9%
1 terminated out of 17 trials
91.7%
+5.2% vs benchmark
41%
7 trials in Phase 3/4
55%
6 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (17)
Asthma Research in Children and Adolescents
Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality and Mitigation of Same on Persistent Asthma
Refractory Asthma Stratification Programme (RASP) Bronchoscopy Study
Cockroach Immunotherapy in Children and Adolescents
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma
Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Efficacy, Safety, and Pharmacokinetics of QAW039
Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients
Study of Safety of Foradil in Patients With Persistent Asthma
Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care
Impact of Lung Flute Therapy on Asthma
Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital
E-nose and Inflammatory Asthma Phenotypes
Asthma Control in Elderly Patients With Montelukast
Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma
Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol